Transforming How Cancer Is Treated: Research Results To Be Shared at ASCO25
May 29, 2025 8:20 AM ET
Campaign:
Corporate Social Responsibility
When Emma was diagnosed with triple-negative breast cancer, she didn't let it define her. There are so many ways cancer steals possibility, but at Gilead, we’re helping take it back. We’ll continue working to transform how cancer is treated — and we look forward to sharing our research at ASCO25.
Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
